Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05963204 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Effects for Midface Improvement When Pairing a Biostimulator with a Skincare Regimen
A NA study, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT05963204 is a NA study that has completed, run by Galderma R&D. The registered enrollment target is 21 participants.
The verdict
NCT05963204, a NA study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
To assess skin structural change in midface after treatment with a biostimulator using Line-Field Optical Coherence Tomography
Interventions
- COMBINATION_PRODUCT Sculptra and Alastin Restorative Skin Complex
- COMBINATION_PRODUCT Sculptra and CeraVe Daily Moisturizing Lotion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2023-07-07 |
| Est. Completion | 2024-03-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05963204
The ClinicalTrials.gov registry entry for NCT05963204 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sculptra and Alastin Restorative Skin Complex is the first listed.
NCT05963204 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05963204 about?
NCT05963204 is a clinical study titled "A Study to Evaluate the Effects for Midface Improvement When Pairing a Biostimulator with a Skincare Regimen". To assess skin structural change in midface after treatment with a biostimulator using Line-Field Optical Coherence Tomography
What is the current status of trial NCT05963204?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2023-07-07. Estimated completion is 2024-03-19.
What interventions are being tested in trial NCT05963204?
The interventions under investigation include: Sculptra and Alastin Restorative Skin Complex (COMBINATION_PRODUCT), Sculptra and CeraVe Daily Moisturizing Lotion (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05963204?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.